Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-rich plasma for diabetic lower-extremity wounds
RBR-6yt2hpRecruiting
- Sponsor
- Universidade Brasil
- Start
- Jan 2020
- Countries
- 1
01
Overview
Open-label trial of platelet-rich plasma in diabetic foot ulcer (DFU) and diabetes mellitus (DM) (2 arms), sponsored by Universidade Brasil. Primary endpoints: Complete wound closure and Wound healing over 12 weeks. Started Jan 2020; status: recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
diabetic foot ulcer (DFU)diabetes mellitus (DM)
Beyond the preview
Go deeper on RBR-6yt2hp.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6yt2hp.